The potential for adulterated dietary supplements to reach the US market during the four months the Food and Drug Administration paused its facility inspections highlights the need for mandatory product listing and could prompt introduction of legislation to impose the requirement.
FDA has informed supplement industry stakeholders it is working on language for a proposal to submit to members of Congress that would codify a mandatory listing process, says
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?